Author

Franco Cavalli

Observed names: Cavalli, Franco, F Cavalli, F. CAVALLI, F. Cavalli

Institutions: Institute of Oncology Research, European School of Oncology

Observed institutions: University of Bern, Rush University Medical Center, The University of Texas at San Antonio Health Science Center, University of Münster, Kantonsspital St. Gallen, Western General Hospital, University Hospital of Bern, NYU Langone Health, Ospedale regionale di Lugano, European School of Oncology, Ospedale San Giovanni Bellinzona, University Hospital Zurich, Institute of Oncology Research, Ospedale Regionale di Locarno, Ospedale Regionale di Mendrisio, Dana-Farber Cancer Institute, Ludwig Cancer Research, European School of Oncology, Centro di Riferimento Oncologico, Swiss Group For Clinical Cancer Research, International Breast Cancer Study Group, Fondazione IRCCS Istituto Nazionale dei Tumori, Istituto Oncologico della Svizzera Italiana, Fondazione Beretta, Rush University, New York University, European Institute of Oncology, University of Göttingen

OpenAlex ID: A5111869822

Primary extranodal non-Hodgkin's lymphomas. Part 1: Gastrointestinal, cutaneous and genitourinary lymphomas

1997 · E. Zucca, E. Roggero, et al. · Annals of Oncology · 408

Burdens and Benefits of Adjuvant Cyclophosphamide, Methotrexate, and Fluorouracil and Tamoxifen for Elderly Patients With Breast Cancer: The International Breast Cancer Study Group Trial VII

2000 · Diana Crivellari, Marco Bonetti, et al. · Journal of Clinical Oncology · 291

Prognostic impact of amenorrhoea after adjuvant chemotherapy in premenopausal breast cancer patients with axillary node involvement: results of the international Breast Cancer Study Group (IBCSG) trial VI

1998 · O. Pagani, A. O’Neill, et al. · European Journal of Cancer · 225

Primary extranodal non-Hodgkin's lymphomas. Part 2: Head and neck, central nervous system and other less common sites

1999 · E. Zucca, E. Roggero, et al. · Annals of Oncology · 177

Clinical Features, Treatment and Outcome in a Series of 93 Patients with Low-Grade Gastric MALT Lymphoma

1997 · Graziella Pinotti, Emanuele Zucca, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 176

Primary Mediastinal B-Cell Lymphoma

2003 · Stefano A. Pileri, Gianluca Gaidano, et al. · American Journal Of Pathology · 167

Quality-of-Life-Adjusted Evaluation of Adjuvant Therapies for Operable Breast Cancer

1991 · Richard D. Gelber, Aron Goldhirsch, et al. · Annals of Internal Medicine · 165

First isolated locoregional recurrence following mastectomy for breast cancer: results of a phase III multicenter study comparing systemic treatment with observation after excision and radiation. Swiss Group for Clinical Cancer Research.

1994 · M Borner, M Bacchi, et al. · Journal of Clinical Oncology · 161

Lymphoma classification--the gap between biology and clinical management is closing

1996 · W Hiddemann, DL Longo, et al. · Blood · 146

Relevance of intraocular involvement in the management of primary central nervous system lymphomas

2002 · A.J.M. Ferreri, J.-Y. Blay, et al. · Annals of Oncology · 136

PDF

Identifying Breast Cancer Patients at High Risk for Bone Metastases

2000 · Marco Colleoni, Anne O’Neill, et al. · Journal of Clinical Oncology · 125

Ocular adnexal MALT lymphoma: an intriguing model for antigen-driven lymphomagenesis and microbial-targeted therapy

2007 · A.J.M. Ferreri, R. Dolcetti, et al. · Annals of Oncology · 120

Pharmacokinetics of VP16-213 given by different administration methods

1982 · M. D'Incalci, P. Farina, et al. · Cancer Chemotherapy and Pharmacology · 120

Acute Myelogenous Leukaemia: Maintenance Chemotherapy After Early Consolidation Treatment Does Not Prolong Survival

1984 · Chr. Sauter, M. Fopp, et al. · The Lancet · 116

Update on the molecular biology of mantle cell lymphoma

2006 · Francesco Bertoni, Andrea Rinaldi, et al. · Hematological Oncology · 100

Randomized trial of low- versus high-dose medroxyprogesterone acetate in the induction treatment of postmenopausal patients with advanced breast cancer.

1984 · F Cavalli, A Goldhirsch, et al. · Journal of Clinical Oncology · 97

First-line fadrozole HCI (CGS 16949A) versus tamoxifen in postmenopausal women with advanced breast cancer

1996 · B. Thürlimann, K. Beretta, et al. · Annals of Oncology · 91

PDF

Reactive perivascular T‐cell infiltrate predicts survival in primary central nervous system B‐cell lymphomas

2007 · M. Ponzoni, F. Berger, et al. · British Journal of Haematology · 86

In vitro activity of cyclin-dependent kinase inhibitor CYC202 (Seliciclib, R-roscovitine) in mantle cell lymphomas

2005 · K. Lacrima, A. Valentini, et al. · Annals of Oncology · 72

Concurrent or sequential use of cytotoxic chemotherapy and hormone treatment in advanced breast cancer: report of the Swiss Group for Clinical Cancer Research.

1983 · F Cavalli, M Beer, et al. · BMJ · 71

PDF

Report on the international workshop on staging and treatment of testicular cancer

1980 · F. Cavalli, S. Monfardini, et al. · European Journal of Cancer (1965) · 69

Formestane versus megestrol acetate in postmenopausal breast cancer patients after failure of tamoxifen: a phase III prospective randomised cross over trial of second-line hormonal treatment (SAKK 20/90)

1997 · B. Thürlimann, M. Castiglione, et al. · European Journal of Cancer · 65

A phase II study of cisplatin in advanced gastric cancer

1983 · Meyir Beer, Giorgio Cocconi, et al. · European Journal of Cancer and Clinical Oncology · 64

The International (Ludwig) Breast Cancer Study Group Trials I-IV: 15 years follow-up

1994 · M. Castiglione-Gertsch, C. Johnsen, et al. · Annals of Oncology · 63

Pathobiology of Primary Mediastinal B-Cell Lymphoma

2003 · Stefano A Pileri, Pier L Zinzani, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 62

Works count: 213

Citation count: 5,847

H-index: 40

I10-index: 103